Episode 114-From Biglaw to In-house to Business Role and Back Again with Carl Berglind

In the last two episodes of Counsel to Counsel, I spoke with a lawyer who left corporate practice for management consulting and a trial lawyer who has built a trial consulting business but continues to try cases. In this episode, I speak with a corporate lawyer who cut his teeth at international law firms, went in-house, moved into a business role, and is back again at an international law firm. Carl Berglind is a Shareholder with Greenberg Traurig’s Health Care & FDA group. He is based in Denver, Colorado. He focuses his practice on M&A and other complex transactions in the healthcare industry,  representing both sellers and investors. In his business roles, Carl served as the CEO of an early stage animal health / AgTech company.  He was also VP of M&A of a private equity backed ophthalmology platform, and Senior Vice President of Strategic Transactions at a Fortune 500 diversified health care services company. Carl was born in Sweden, and grew up in New York, Copenhagen, and Brussels. He speaks fluent Swedish and conversationally fluent French and Danish. He uses his background by working with international clients in addition to his domestic health care transactional practice. Additional Resources Episode 113-From Litigation to Trial Consulting with Marc Diller Episode 112-From Corporate Counsel to Management Consultant-Leveraging Your Legal Career with David Lesser Episode 96-David Abromowitz-Practicing Law in the Public Interest at an AmLaw200 Firm